Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in APLS / Apellis Pharmaceuticals, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 65,156 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -65,156 -100.00 0 -100.00
2025-11-13 2025-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 65,156 65,156 1,474 0.0017
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -204,803 -100.00 0 -100.00
2025-08-14 2025-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 204,803 3,736 1.86 4,479 -30.19 0.0056
2025-05-15 2025-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 204,803 3,736 4,479 0.0059
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 201,067 17,778 9.70 6,416 21.38 0.0078
2024-11-14 2024-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 183,289 -1,642 -0.89 5,286 -25.49 0.0057
2024-08-09 2024-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 184,931 -36,723 -16.57 7,094 -45.55 0.0081
2024-05-14 2024-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 221,654 -361,775 -62.01 13,029 -62.69 0.0148
2024-02-14 2023-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 583,429 -493,119 -45.81 34,924 -14.72 0.0403
2023-11-14 2023-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 1,076,548 301,068 38.82 40,952 -42.03 0.0514
2023-10-27 2023-06-30 13F/A-2 APELLIS PHARMACEUTICALS COM 03753U106 775,480 -635,999 -45.06 70,646 -24.12 0.0808
2023-10-12 2023-06-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 775,480 -635,999 70,646 0.0710
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 775,480 -635,999 70,646 0.0717
2023-06-01 2023-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 1,411,479 -50,163 -3.43 93,101 23.18 0.1106
2023-05-15 2023-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,411,479 -50,163 93,101 0.0855
2023-02-21 2022-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,461,642 40,107 2.82 75,582 -22.23 0.0893
2022-11-14 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 1,421,535 38,028 2.75 97,182 55.34 0.1192
2022-08-17 2022-06-30 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 1,383,507 61,949 4.69 62,562 -6.83 0.0702
2022-08-15 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 1,383,507 61,949 62,562 0.0224
2022-05-16 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 1,321,558 29,775 2.30 67,149 9.95 0.0511
2022-02-11 2021-12-31 13F Apellis Pharmaceuticals COM 03753U106 1,291,783 171,693 15.33 61,075 65.43 0.0509
2021-11-12 2021-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 1,120,090 574,416 105.27 36,918 7.05 0.0315
2021-08-13 2021-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 545,674 543,529 25,339.35 34,487 37,385.87 0.0283
2021-05-14 2021-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 2,145 -717 -25.05 92 -43.90 0.0001
2021-02-16 2020-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 2,862 0 0.00 164 90.70 0.0002
2020-11-13 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 2,862 0 0.00 86 -7.53 0.0001
2020-08-11 2020-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 2,862 2,862 93 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.